Once lung cancer is suspected on a scan, minimally invasive diagnostic procedures and comprehensive biomarker testing are ...
Australian Patent Office accepts bioAffinity Technologies' patent application for its platform technology to assess lung health and predict disease.
A major new study, which has recently begun recruiting, is hoped to lead to earlier detection of lung cancers.